ZenoWell
ZenoWell designs and sells wearable non-invasive auricular vagus nerve stimulation (taVNS) devices (Luna, Vita) for consumer wellness, targeting sleep, stress, pain, and recovery, and sells globally direct-to-consumer with consumables-based recurring revenue.
- Company typePrivate
- Founded-
- HeadquartersPotsdam, Germany
- Headcount11–50
- GTM typeB2C
- OfferingHardware or Manufacturing
What ZenoWell does
ZenoWell is a private neurotechnology company that designs, manufactures, and sells wearable transcutaneous auricular vagus nerve stimulation (taVNS) devices for consumer wellness use. Its core products, the ZenoWell Luna ($409-$499) and ZenoWell Vita ($269-$479), are handheld controllers paired with electrode earpieces that target the auricular branch of the vagus nerve through two innervation-rich sites in the ear (cymba conchae and cavum concha), a configuration the company claims differentiates it from single-site competitors. The technology originated in Prof. Hocher's lab at Heidelberg University and is supported by an in-house research platform called BrainCLOS, developed with Swiss partner BEE Medic, which is used in studies at Cambridge, Heidelberg, and Charité Berlin.
The company monetizes primarily through one-time hardware sales via its own e-commerce storefront (zenowell.ai) with global shipping to the EU, UK, and selected international destinations, supplemented by recurring consumables revenue from replacement electrode earpieces ($129) and conductive gel packs ($59 for a five-month supply). Devices operate standalone without an app or subscription, and the company relies on a multi-channel GTM motion spanning DTC e-commerce, trade shows (CES, IFA, DGPPN, ACAN), community-led education through the Vagus Nerve Society and monthly webinars, and earned media partnerships with outlets including Vogue Italia and Cybernews.
Operationally, ZenoWell is structured as ZENOWELL LIMITED, registered in Hong Kong, with engineering and R&D teams in Heidelberg, Berlin, Shenzhen, and Hong Kong, and research collaborations extending to Stanford. The company holds CE, FCC, and RoHS certifications, reports 2M+ patient sessions with zero serious adverse events in referenced clinical trials, and is led by co-founders Jo Xue (CEO), Dr. Jane Xiao (Chief Scientist), and Prof. Berthold Hocher (Initiator), backed by a scientific advisory board drawn from Heidelberg, Charité, Cambridge, Harvard, Stanford, and CUHK. The most significant recent strategic action is a 2026 cooperation agreement with USound to integrate ultrasound-based physiological sensing into next-generation ear-worn devices, signaling a planned shift from discrete stimulation sessions toward continuous biometric monitoring.
ZenoWell firmographics
Firmographics- Name
- ZenoWell
- Legal name
- ZENOWELL LIMITED
- Website
- https://zenowell.ai
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ZenoWell designs and sells wearable non-invasive auricular vagus nerve stimulation (taVNS) devices (Luna, Vita) for consumer wellness, targeting sleep, stress, pain, and recovery, and sells globally direct-to-consumer with consumables-based recurring revenue.
- Ownership category
- akta.pro rank
ZenoWell industry classification
Industry- Product category
- Wearable Neurotechnology Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices) (CRACAQAL)
- akta.pro secondary industry
- Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices) (CRACAQAK)
Keywords
Where ZenoWell is headquartered
LocationHeadquarters
- HQ city
- Potsdam
- HQ country
- Germany
- HQ region
- Europe
Offices6 records
Markets served
ZenoWell business model
Business model- GTM type
- B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- Hardware Device Sales: One-time purchase of taVNS devices (Luna and Vita) with no ongoing subscription required. Standalone operation without app dependency. Accessory purchases for consumables and replacements
- Accessories and Consumables: Replacement earpieces ($129), conductive gel packs ($59), warranty cards. Ongoing revenue from consumables with 5-month supply cycle per gel pack
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Pay-as-you-go | ZenoWell Vita - Entry-level taVNS device |
| One time/ perpetual license | Pay-as-you-go | ZenoWell Luna - Advanced taVNS device |
| Unit Pricing | Pay-as-you-go | Electrode Earpiece - Replacement accessory |
| Unit Pricing | Pay-as-you-go | Gel Pack - Conductive gel consumable |
| One time/ perpetual license | Pay-as-you-go | Warranty Card Extension |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels8 records
ZenoWell product offering
Product offeringCore offering
ZenoWell designs, manufactures, and sells wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices — Luna (4 modes, $409 sale) and Vita (3 modes, $269 sale) — paired with proprietary electrode earpieces and conductive gel consumables. The devices stimulate the auricular branch of the vagus nerve via the ear to address sleep, stress, headache, fatigue, and recovery concerns. The company operates a direct-to-consumer e-commerce store (zenowell.ai) shipping globally with no subscription or app required for device operation.
Product overview
ZenoWell offers a portfolio of wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices. The core products are ZenoWell Luna and ZenoWell Vita, both handheld controller devices paired with electrode earpieces that stimulate the auricular branch of the vagus nerve through the ear. Luna features four modes (Relief, Sleep, Relax, Medit) with 8-hour battery life for headache, sleep, stress, and pain applications, while Vita offers three modes (Sleep, Relax, Meditation) with 4-hour battery life focused on sleep and relaxation. Both devices use conductive gel with their earpieces and are accompanied by consumable gel packs. The ecosystem is supported by the BrainCLOS research platform providing clinical-grade studies for healthcare professionals. The company originated from Heidelberg University and collaborates with institutions including Harvard and Cambridge.
Differentiator
Problem solved
Functional benefit
Brands
- BrainCLOS: Research-grade vagus nerve stimulation system developed in collaboration with BEE Medic Switzerland, used in clinical studies at Cambridge University, Heidelberg University, and Charité Berlin
Products and services
- ZenoWell Luna Advanced wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with four modes (Relief, Sleep, Relax, Medit) designed for headache relief, sleep improvement, stress reduction, and pain/fatigue management. Features 8-hour battery supporting 24 sessions and targets the auricular branch of the vagus nerve via a paired electrode earpiece.
- ZenoWell Vita Wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) device with three modes (Sleep, Relax, Meditation) designed to enhance sleep, reduce stress and tension, and alleviate fatigue by stimulating the auricular branch of the vagus nerve. Features 4-hour battery supporting 12 sessions.
- ZenoWell Electrode Earpiece
Quantifiable outcome
- 25% deeper sleep, 45% less stress, 12% higher HRV, 30% less headache discomfort
- +5 more outcomes
Companies that use ZenoWell
Customer profileNamed customers7 records
Segments7 records
Ideal customer profiles2 records
ZenoWell technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
ZenoWell partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- USoundcoreStrategic cooperation to explore integration of USound's advanced MEMS-based sensing technologies into next-generation wearable health devices. Collaboration aims to combine USound's ultrasound-based physiological sensing capabilities with ZenoWell's ear-based vagus nerve stimulation platform to enable continuous biometric monitoring for sleep, pain, anxiety, and mental health applications. USound holds over 500 patents protecting its MEMS loudspeaker and ultrasound sensing technology.
- G-PACT (Gastroparesis Awareness)minorPartnership to promote GI health education during Gastroparesis Awareness Month. Collaborative educational initiatives for gut-brain axis awareness.
- BEE Medic (Switzerland)coreCollaboration to bring ZenoWell's vision to life. Together with BEE Medic, they launched the first research-grade system: BrainCLOS, which became part of studies at Cambridge University, Heidelberg University, and Charité Berlin.
- Heidelberg UniversitycoreOrigin of ZenoWell technology from Prof. Hocher's lab at Heidelberg University. Ongoing research collaboration with academic institution.
- Charité BerlincoreResearch collaboration with Charité University Medicine Berlin. Prof. Pommer from Charité is part of the scientific advisory board.
- Cambridge UniversitycoreAcademic research collaboration with Cambridge University. Prof. Voon from Cambridge is part of the scientific advisory board.
- Vagus Nerve SocietyminorAffiliation with Vagus Nerve Society (vnsociety.org) for professional networking and knowledge sharing in the VNS field.
- Stanford UniversityminorResearch collaboration with Stanford University. Stanford GMIX Project Group has visited ZenoWell facilities.
Scale indicators6 records
Recent moves6 records
Expansion highlights6 records
ZenoWell competitors and assessment
Company assessmentDirect peers
- Parasym: Parasym offers a consumer ear-electrode tVNS device targeting stress, sleep, and anxiety. Directly comparable to ZenoWell on modality (auricular vagus stimulation), customer use cases, and D2C wellness positioning.
- electroCore: electroCore markets gammaCore, an FDA-cleared non-invasive vagus nerve stimulation device for migraine, cluster headache, and other indications. Closest direct competitor by modality, but differentiated by medical-device clearance and physician channel rather than ZenoWell's wellness D2C positioning.
- Truvaga: Truvaga sells a consumer handheld transcutaneous vagus nerve stimulation device marketed for stress, sleep, and mood. It is the most direct head-to-head competitor to ZenoWell's Luna and Vita, with overlapping ear-electrode delivery, wellness positioning, and D2C channel.
Broad incumbents
- Muse (Interaxon): Muse is a consumer EEG brain-sensing headband for meditation, focus, and sleep. Comparable as a consumer neurotechnology wearable in the wellness channel targeting stress and sleep, though sensing-based rather than stimulation-based.
- Whoop: Whoop is a subscription-based wearable for sleep, recovery, and strain tracking. Comparable as a broader incumbent wellness wearable platform targeting sleep and stress/recovery with strong consumer brand and recurring revenue model that ZenoWell currently lacks.
- Apollo Neuroscience: Apollo sells a wearable stress and sleep device that delivers low-frequency vibrations to modulate the nervous system. Comparable as a consumer neuromodulation wellness wearable targeting stress, sleep, and recovery, though using a different stimulation modality than ZenoWell's electrical taVNS.
- Neuvana: Neuvana sells a consumer earbud-style vagus nerve stimulation device marketed for relaxation, focus, and sleep. Comparable as a consumer VNS wearable in the wellness channel, though positioned through lifestyle/audio use rather than ZenoWell's clinical-research framing.
- Oura: Oura makes a smart ring for sleep, readiness, and recovery. Comparable as a broader incumbent consumer wearable with strong scientific credibility, recurring subscription revenue, and overlapping sleep/stress use cases that ZenoWell addresses.
Regional players
- Ceragem: Ceragem manufactures thermal massage and wellness devices, primarily in Asian markets. Comparable at a category level as a consumer wellness-device brand with overlapping lifestyle/health positioning, though focused on thermal therapy rather than vagus nerve stimulation.
Emerging players
- Hoolest Performance Technologies: Hoolest develops consumer vagus nerve stimulation wearables positioned for performance and stress. Smaller-scale emerging player with overlapping auricular VNS technology and consumer health use cases versus ZenoWell.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks7 records
Key highlights7 records
Customer concentration
ZenoWell social profiles
Digital presenceZenoWell compliance and trust
Trust signalCompliance3 records
ZenoWell financial estimates
Financial estimateRevenue estimate
Valuation estimate
ZenoWell leadership team
Management profileNumber of profiles
Profiles3 records
ZenoWell funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ZenoWell M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ZenoWell
What does ZenoWell do?
ZenoWell designs, manufactures, and sells wearable non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) devices — Luna (4 modes, $409 sale) and Vita (3 modes, $269 sale) — paired with proprietary electrode earpieces and conductive gel consumables. The devices stimulate the auricular branch of the vagus nerve via the ear to address sleep, stress, headache, fatigue, and recovery concerns. The company operates a direct-to-consumer e-commerce store (zenowell.ai) shipping globally with no subscription or app required for device operation.
Is ZenoWell a public or private company?
ZenoWell is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was ZenoWell founded?
ZenoWell was founded in -1. It employs 11 to 50 people.
Where is ZenoWell based?
ZenoWell is headquartered in Potsdam, Germany, in the Europe region.
How does ZenoWell make money?
Two revenue lines are on record. Hardware Device Sales are the primary driver. The others are accessories and Consumables.
Who are ZenoWell's main competitors?
Direct peers on record are Parasym, electroCore and Truvaga. Broad incumbents are Muse (Interaxon), Whoop, Apollo Neuroscience, Neuvana and Oura. Ceragem is listed as a regional player. Hoolest Performance Technologies is listed as an emerging player.
Does ZenoWell have an API?
No public API is recorded for ZenoWell.
What industry is ZenoWell in?
ZenoWell's product category is Wearable Neurotechnology Devices. Its primary akta.pro industry code is CRACAQAL, Mental Wellness & Stress Management Devices (Biofeedback, Meditation/Neurostimulation Devices), with a secondary code of CRACAQAK, Posture, Musculoskeletal & Pain-Relief Devices (Posture Trainers, TENS/EMS, Massage Devices). Its NAICS code is 334510 and its SIC code is 3845.